Overview M&A Advisory Private Equity Financing
Representative Clients Principal Contact Home
     
             
       
           
       
     

Animas Corporation (Medical Devices – insulin pumps for the diabetes market, acquired by Johnson & Johnson)

 

Private Equity*

 
     

Carter-Wallace, Inc. (Specialty Pharma, acquired by MedPointe
Pharmaceuticals)

 

M&A Advisory

 
     

Gentium S.p.A. (Biotechnology – treatment of vascular disease and oncology-related conditions) NASDAQ:GENT

 

M&A Advisory/ PIPE

 
     

Kos Pharmaceuticals, Inc. (Specialty Pharma – cardiovascular, acquired by Abbott Laboratories)

 

IPO/ M&A Advisory

 
     

Medicis Pharmaceutical Corp. (Specialty Pharma – dermatology)
NYSE:MRX

 

M&A Advisory

 
     

NMT Medical, Inc. (Medical Devices – minimally invasive solutions for the treatment of cardiac sources of stroke) NASDAQ:NMTI

 

Private Equity*/ M&A Advisory

 
             
           
     

Afferon Corporation (Specialty Pharma – urology)

 

M&A Advisory

 
     

DentalXChange, Inc. (Online Dental Services, acquired by MetLife)

 

Private Equity

 
     

Endius Inc. (Medical Devices – minimally-invasive spine surgery, acquired by Zimmer Holdings)

 

Private Equity

 
     

Integrity Pharmaceutical Corporation (Specialty Pharma – women's health, merged with Xanodyne Pharmaceuticals)

 

M&A Advisory

 
     

Richwood Pharmaceutical Company (Specialty Pharma–ADHD drug ADDERALL®, acquired by Shire Pharmaceuticals)

 

M&A Advisory

 
     

SCIREX Corporation (CRO, acquired by Omnicom)

 

Private Equity/ M&A Advisory

 
     

UtiliMED, Inc. (Radiology Services, acquired by American Imaging
Management)

 

M&A Advisory

 
             
     

* While private.